章源鎢業(002378.SZ)業績快報:2021年度淨利潤升342.09%至1.64億元
格隆匯3月11日丨章源鎢業(002378.SZ)發佈2021年度業績快報,實現營業總收入26.64億元,同比增長37.97%;歸屬於上市公司股東的淨利潤1.64億元,同比增長342.09%;扣除非經常性損益後的歸屬於上市公司股東的淨利潤1.31億元,上年同期為虧損2173.67萬元;基本每股收益0.18元。
報吿期鎢行業延續了快速增長的態勢,市場需求穩步回升,主要產品產銷量、銷售價格同比增長,歸屬於上市公司股東淨利潤同比大幅增長。
公司全資子公司贛州澳克泰工具技術有限公司堅持自主創新,管理更趨精細,隨着國產高端刀具需求增加,收入實現規模增長,業績大幅提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.